BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 23436166)

  • 1. Emerging and mechanism-based therapies for recurrent or metastatic Merkel cell carcinoma.
    Miller NJ; Bhatia S; Parvathaneni U; Iyer JG; Nghiem P
    Curr Treat Options Oncol; 2013 Jun; 14(2):249-63. PubMed ID: 23436166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in Immunotherapy for Metastatic Merkel Cell Carcinoma: A Clinician's Guide.
    Paulson KG; Bhatia S
    J Natl Compr Canc Netw; 2018 Jun; 16(6):782-790. PubMed ID: 29891528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Merkel Cell Carcinoma in the Age of Immunotherapy: Facts and Hopes.
    Colunga A; Pulliam T; Nghiem P
    Clin Cancer Res; 2018 May; 24(9):2035-2043. PubMed ID: 29217527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale for immune-based therapies in Merkel polyomavirus-positive and -negative Merkel cell carcinomas.
    Vandeven N; Nghiem P
    Immunotherapy; 2016 Jul; 8(8):907-21. PubMed ID: 27381685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scientific and clinical developments in Merkel cell carcinoma: A polyomavirus-driven, often-lethal skin cancer.
    Akaike T; Nghiem P
    J Dermatol Sci; 2022 Jan; 105(1):2-10. PubMed ID: 34836718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Merkel cell carcinoma: recent insights and new treatment options.
    Schrama D; Ugurel S; Becker JC
    Curr Opin Oncol; 2012 Mar; 24(2):141-9. PubMed ID: 22234254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Merkel cell carcinoma: Do you know your guidelines?
    Miles BA; Goldenberg D;
    Head Neck; 2016 May; 38(5):647-52. PubMed ID: 26716756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on the biology and clinical management of Merkel cell carcinoma.
    Thakuria M; LeBoeuf NR; Rabinowits G
    Am Soc Clin Oncol Educ Book; 2014; ():e405-10. PubMed ID: 24857131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Merkel cell carcinoma: a highly aggressive tumor with possible viral etiology].
    Toberer F; Werchau S; Bischof M; Büchler M; Enk A; Helmbold P
    Chirurg; 2011 Aug; 82(8):653-60. PubMed ID: 21290092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in the understanding of the genetics, etiology, and treatment of Merkel cell carcinoma.
    Donepudi S; DeConti RC; Samlowski WE
    Semin Oncol; 2012 Apr; 39(2):163-72. PubMed ID: 22484188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Merkel cell carcinoma: Epidemiology, prognosis, therapy and unmet medical needs.
    Schadendorf D; Lebbé C; Zur Hausen A; Avril MF; Hariharan S; Bharmal M; Becker JC
    Eur J Cancer; 2017 Jan; 71():53-69. PubMed ID: 27984768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Merkel cell polyomavirus in merkel cell carcinoma: clinical and therapeutic perspectives.
    Samimi M; Gardair C; Nicol JT; Arnold F; Touzé A; Coursaget P
    Semin Oncol; 2015 Apr; 42(2):347-58. PubMed ID: 25843739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidisciplinary Treatment, Including Locoregional Chemotherapy, for Merkel-Polyomavirus-Positive Merkel Cell Carcinomas: Perspectives for Patients Exhibiting Oncogenic Alternative Δ exon 6-7 TrkAIII Splicing of Neurotrophin Receptor Tropomyosin-Related Kinase A.
    Guadagni S; Farina AR; Cappabianca LA; Sebastiano M; Maccarone R; Zelli V; Clementi M; Chiominto A; Bruera G; Ricevuto E; Fiorentini G; Sarti D; Mackay AR
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33153070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality Is King: Fundamental Insights into Tumor Antigenicity from Virus-Associated Merkel Cell Carcinoma.
    Lahman MC; Paulson KG; Nghiem PT; Chapuis AG
    J Invest Dermatol; 2021 Aug; 141(8):1897-1905. PubMed ID: 33863500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunobiology of Merkel cell carcinoma: implications for immunotherapy of a polyomavirus-associated cancer.
    Bhatia S; Afanasiev O; Nghiem P
    Curr Oncol Rep; 2011 Dec; 13(6):488-97. PubMed ID: 21953511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Merkel cell carcinoma: emerging biology, current approaches, and future directions.
    Tothill R; Estall V; Rischin D
    Am Soc Clin Oncol Educ Book; 2015; ():e519-26. PubMed ID: 25993218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Therapeutic Advances and Change in Treatment Paradigm of Patients with Merkel Cell Carcinoma.
    Garcia-Carbonero R; Marquez-Rodas I; de la Cruz-Merino L; Martinez-Trufero J; Cabrera MA; Piulats JM; Capdevila J; Grande E; Martin-Algarra S; Berrocal A
    Oncologist; 2019 Oct; 24(10):1375-1383. PubMed ID: 30962295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Updates on Merkel Cell Carcinoma.
    Emge DA; Cardones AR
    Dermatol Clin; 2019 Oct; 37(4):489-503. PubMed ID: 31466589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct merkel cell polyomavirus molecular features in tumour and non tumour specimens from patients with merkel cell carcinoma.
    Laude HC; Jonchère B; Maubec E; Carlotti A; Marinho E; Couturaud B; Peter M; Sastre-Garau X; Avril MF; Dupin N; Rozenberg F
    PLoS Pathog; 2010 Aug; 6(8):e1001076. PubMed ID: 20865165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the IDO1/TDO2-AhR pathway in tumor cells or the tumor microenvironment is associated with Merkel cell polyomavirus status and prognosis in Merkel cell carcinoma.
    Wardhani LO; Matsushita M; Iwasaki T; Kuwamoto S; Nonaka D; Nagata K; Kato M; Kitamura Y; Hayashi K
    Hum Pathol; 2019 Feb; 84():52-61. PubMed ID: 30240768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.